Profile
Wolfgang Trefzger came in 2007 to HI and is our contact person to Investors, Boards and external Institutions regarding all financial issues.
He is working for 15 years in Life Science Industries on a management and executive level, thereof 12 being in charge of financials.
During the last six years he focused on Biotech having responsibility for business plans, funding, controlling and reporting as well as for all other administrative functions.
Mr Trefzger started his career in machinery and measurement and control industries, where he applied his studies in social sciences (M.A.) and systems analysis leading organisational projects.
This view integrating all operating processes of a company then gave reason to take on commercial responsibility in a medical device company.
His experience working at the interface of science based business concepts, organisational issues and financial needs will be an appreciated link between our investors and our portfolio management.
Former positions of Wolfgang Trefzger
| Companies | Position | End |
|---|---|---|
Heidelberg Innovation Fonds Management GmbH
 Heidelberg Innovation Fonds Management GmbH Investment ManagersFinance Heidelberg Innovation Fonds Management GmbH (Heidelberg Innovation) is an independent German venture capital firm which was founded in 1997 by Dr. Ulrich Abshagen. In addition to providing financial capital, Heidelberg Innovation's 'network and knowledge capital', in the form of entrepreneurial experience, technical expertise and their network of experts and contacts, is a decisive added value for their investee companies. Based in Leimen, the firm manages the Heidelberg Innovation BioScience Venture II, Heidelberg Innovation Parallel Participation and the Heidelberg Innovation BioScience Venture I funds for investors including the European Investment Fund, insurance companies, banks, fund-of-fund investors and private individuals. | Director of Finance/CFO | 2017-03-28 |
Digilab BioVisioN GmbH
 Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Director of Finance/CFO | 2002-01-01 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Heidelberg Innovation Fonds Management GmbH
Heidelberg Innovation Fonds Management GmbH Investment ManagersFinance Heidelberg Innovation Fonds Management GmbH (Heidelberg Innovation) is an independent German venture capital firm which was founded in 1997 by Dr. Ulrich Abshagen. In addition to providing financial capital, Heidelberg Innovation's 'network and knowledge capital', in the form of entrepreneurial experience, technical expertise and their network of experts and contacts, is a decisive added value for their investee companies. Based in Leimen, the firm manages the Heidelberg Innovation BioScience Venture II, Heidelberg Innovation Parallel Participation and the Heidelberg Innovation BioScience Venture I funds for investors including the European Investment Fund, insurance companies, banks, fund-of-fund investors and private individuals. | Finance |
Digilab BioVisioN GmbH
Digilab BioVisioN GmbH Miscellaneous Commercial ServicesCommercial Services Digilab BioVisioN GmbH provides research services in the area of peptide analysis to health care by discovering and developing novel substances and methods to diagnose and treat human diseases. Its partners include Roche Diagnostics GmbH for the discovery of novel biomarker candidates of Alzheimer's disease and Novo Nordisk for the search for novel therapeutic approaches in type 2 diabetes. The company was founded in 1997 and is headquartered in Hannover, Germany. | Commercial Services |
- Stock Market
- Insiders
- Wolfgang Trefzger
